People
René Chaze is a director of NeuroVision Imaging and a Partner at Tiny Orange Capital. His experience spans strategy, operations and finance across technology and life-science investments. He previously served as CFO, COO and head of mergers and acquisitions at Edelman Financial Services and was an Ernst & Young partner. NeuroVision’s current own board biography identifies René Chaze as Partner at Tiny Orange Capital, focusing on high-growth technology including blockchain, digital assets and life sciences. He brings more than 35 years of strategy, operations and finance experience, previously CFO, COO and head of M&A at Edelman Financial Services and an Ernst & Young partner. Board and manager roles do not imply a personal investment. René Chaze is named a Durin director in the issuer’s2019–2025 SEC disclosures. His separate current NeuroVision director and Tiny Orange Capital partner affiliations remain preserved. Board service does not alone prove personal investment; any NJEDA-reported investment requires distinct ticket/date qualification.
- Current affiliation
- Tiny Orange Capital · Partner
- Investment range
- — – —
- Sweet spot
- —
- Investments on record
- 2
Investments
| $—Unknown date |  Durin Life Sciences | Breakthrough Diagnostics, LLC, Rene Chaze |
| $—Unknown date | Durin Life Sciences | Breakthrough Diagnostics, LLC, Rene Chaze |
Roles
Director
Partner
Director (historical:2019–2025 SEC disclosures)